Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Emotional Stress on Immune Checkpoint Inhibitor Treatment Outcomes in Hepatocellular Carcinoma: A Multicohort Clinical Study

NCT07141056 is registered in ClinicalTrials.gov with Guilin Medical University, China as lead sponsor.

NCT NCT07141056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07141056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Emotional Stress on Immune Checkpoint Inhibitor Treatment Outcomes in Hepatocellular Carcinoma: A Multicohort Clinical Study
Lead sponsor
Guilin Medical University, China
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
700 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, treatment-related, hcc - hepatocellular carcinoma, immune checkpoint inhibitors (icis), psychological distress, unresectable hepatocellular carcinoma